EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Interpretation of Elevated Baseline Concentrations and Serial Changes of High-Sensitivity Cardiac Troponin T in Confirmed Muscular Dystrophies

Mustafa Yildirim iD, Christoph Reich, Christian Salbach, Regina Pribe-Wolferts, Barbara Ruth Milles, Tobias Täger, Matthias Mueller-Hennessen, Markus Weiler, Benjamin Meder, Norbert Frey, Evangelos Giannitsis

ESC Heart Failure · 2024

DOI: 10.1002/ehf2.14864 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ESC Heart Failure, 2024. Verfasst von Mustafa Yildirim und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine III, Cardiology, University Hospital of Heidelberg, Heidelberg, Germany. Hauptthemen laut MEDLINE: Troponin T, Biomarkers, Muscular Dystrophies. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Roche Diagnostics.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Concentrations of high-sensitivity cardiac troponin T (hs-cTnT) are frequently elevated in stable patients with confirmed muscle dystrophies. However, sparse information is available on the interpretation of serial concentration changes.

Methods

Hs-cTnT was collected in 35 stable outpatients with confirmed skeletal muscle dystrophies at 0 and 1 h and after 6–12 months during scheduled outpatient visits. We simulated the effectiveness of the European Society of Cardiology (ESC) 0/1 h algorithm and assessed biological variation at 6–12 months using two established methods: reference change value (RCV) and minimal important difference (MID).

Results

Median baseline hs-cTnT concentrations were 34.4 ng/L [inter-quartile range (IQR): 17.5–46.2], and values > 99th percentile upper limit of normal were present in 34 of 35 patients. All patients were stable without cardiovascular adverse events during a follow-up of 6.6 months (IQR: 6–7). Median concentration change was 1.9 ng/L (IQR: 0.7–3.2) and 0.8 ng/L (IQR: 0–7.0) at 60 min and 6–9 months, respectively. Applying the criteria of the ESC 0/1 h algorithm for triage of suspected acute coronary syndrome (ACS) showed poor overall effectiveness of baseline hs-cTnT values. No patient would qualify for rule-out based on hs-cTnT less than the limit of detection, whereas five cases would qualify for rule-in based on hs-cTnT ≥ 52 ng/L. Biological variabilities at 6–12 months per MID and RCV were 1.2 ng/L [95% confidence interval (CI): 0.7–2.1] and 28.6% (95% CI: 27.9–29.6), respectively. A total of 8 (22.9%) and 25 (71.4%) cases exceeded the biological variation range, suggesting some additional myocardial damage.

Conclusions

The high prevalence of elevated hs-cTnT could negatively impact the effectiveness of rule-out and rule-in strategies based on a single hs-cTnT value. Knowledge of the physiological and biological variation of hs-cTnT after 6–12 months is helpful to detect the progression of cardiac involvement or to search for cardiac complications including but not limited to arrhythmias that may trigger acute or chronic myocardial damage.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Troponin TBiomarkersMuscular DystrophiesHumansMaleFemaleAdultFollow-Up StudiesMiddle AgedAlgorithms

Stichwörter der Autor:innen

ESC 0/1 h algorithmbiological variationhigh‐sensitivity cardiac troponinskeletal muscle dystrophies

Substanzen

Troponin TBiomarkers

Autor:innen und Institutionen

  • Department of Internal Medicine III, Cardiology, University Hospital of Heidelberg, Heidelberg, Germany.
  • Institute for Cardiomyopathies & Center for Cardiogenetics, Department of Medicine III, Heidelberg University, Heidelberg, Germany.
  • Department of Neurology, University Hospital of Heidelberg, Heidelberg, Germany.
  • German Centre for Cardiovascular Research (DZHK), Heidelberg, Germany.
  • Stanford Genome Technology Center, Stanford University School of Medicine, Palo Alto, California, USA.

ORCID-Profile: Mustafa Yildirim

Förderung

  • Roche Diagnostics

Zitieren

APA

Yildirim, M., Reich, C., Salbach, C., Pribe-Wolferts, R., Milles, B. R., Täger, T., Mueller-Hennessen, M., Weiler, M., Meder, B., Frey, N., & Giannitsis, E. (2024). Interpretation of Elevated Baseline Concentrations and Serial Changes of High-Sensitivity Cardiac Troponin T in Confirmed Muscular Dystrophies. ESC Heart Failure. https://doi.org/10.1002/ehf2.14864

Vancouver

Yildirim M, Reich C, Salbach C, Pribe-Wolferts R, Milles BR, Täger T, et al. Interpretation of Elevated Baseline Concentrations and Serial Changes of High-Sensitivity Cardiac Troponin T in Confirmed Muscular Dystrophies. ESC Heart Failure. 2024. doi:10.1002/ehf2.14864

BibTeX
@article{Yildirim2024,
  author = {Yildirim, Mustafa and Reich, Christoph and Salbach, Christian and Pribe-Wolferts, Regina and Milles, Barbara Ruth and Täger, Tobias and Mueller-Hennessen, Matthias and Weiler, Markus and Meder, Benjamin and Frey, Norbert and Giannitsis, Evangelos},
  title = {Interpretation of Elevated Baseline Concentrations and Serial Changes of High-Sensitivity Cardiac Troponin T in Confirmed Muscular Dystrophies},
  journal = {ESC Heart Failure},
  year = {2024},
  doi = {10.1002/ehf2.14864}
}
Kostenlos starten →